Treatment of Expiratory Wheezes Without Distress

Initial Assessment and Treatment Approach

The American Academy of Family Physicians recommends initiating treatment with an inhaled short-acting beta-2 agonist (albuterol) via metered-dose inhaler with spacer, 2 puffs (200-400 mcg) every 4-6 hours as needed for patients with expiratory wheezes but no respiratory distress 1, 2
The absence of distress indicates a mild episode that does not meet criteria for acute severe asthma, which would include inability to complete sentences, respiratory rate ≥25/min, heart rate ≥110/min, or peak expiratory flow <50% predicted 2, 3, 4

Administer albuterol 200-400 mcg (2 puffs) via metered-dose inhaler with spacer every 4-6 hours as needed for symptom relief, as recommended by the American Academy of Family Physicians 1, 2
Alternative: terbutaline 500-1000 mcg via hand-held inhaler every 4 hours, according to the British Thoracic Society 2, 3
The metered-dose inhaler with spacer is equally effective as nebulizer treatment when proper technique is used and sufficient puffs are administered, as stated by the American Academy of Family Physicians 1

Proper inhaler technique is critical, and patients should be directly observed and regularly reviewed to ensure correct technique, as emphasized by the American Academy of Family Physicians 1
Spacer use is strongly encouraged as it improves drug delivery and reduces the need for perfect coordination, according to the American Academy of Family Physicians 1

If symptoms persist or worsen despite initial treatment, increase frequency to every 2-4 hours as needed, as recommended by the American Academy of Family Physicians 1
Consider increasing dose to 400 mcg (4 puffs) if inadequate response, according to the British Thoracic Society 2, 3
Reassess for signs of worsening, including increased work of breathing, inability to speak in full sentences, or declining peak flow, as stated by the American Academy of Family Physicians and the British Thoracic Society 1, 4

Monitor for development of acute severe features that would necessitate more aggressive therapy, including inability to complete sentences, respiratory rate >25/min, heart rate >110/min, or peak expiratory flow <50% predicted or personal best, as recommended by the British Thoracic Society 2, 3, 4
If these develop, escalate to nebulized albuterol 5 mg plus oral corticosteroids plus oxygen, and consider adding ipratropium bromide 500 mcg if no improvement, according to the British Thoracic Society 2, 3, 4

Do not use short-acting beta-agonists as monotherapy for chronic asthma management, and if the patient requires frequent use of rescue medication, this indicates inadequate control and need for initiation or escalation of controller therapy with inhaled corticosteroids, as recommended by the American Academy of Family Physicians 1

Provide written instructions on when to use the inhaler and when to seek medical attention, and teach recognition of worsening symptoms, as emphasized by the American Academy of Family Physicians 1
Emphasize that increasing need for rescue medication signals worsening control requiring medical evaluation, according to the American Academy of Family Physicians 1

Two puffs from a metered-dose inhaler are NOT equivalent to a nebulizer treatment, and studies showing comparable effects used 6-10 puffs sequentially, as stated by the American Academy of Family Physicians 1
Avoid prescribing home nebulizer therapy without formal assessment by a respiratory specialist, particularly for chronic use, as recommended by the British Thoracic Society 6, 7